By simulating molecular dynamics,
St. Jude scientists revealed how the selectivity or promiscuity of GPCR coupling relies on the location and duration of intermolecular interactions.
Investigators will present research at the annual meeting of the American Society of Hematology, with findings from the
St. Jude Lifetime cohort study.
St. Jude CEO James R. Downing MD is currently leading the $12.9 billion six-year strategic plan, the largest investment in its 60-year history to advance the study and treatment of pediatric cancer and other catastrophic diseases.
Hero Among Us award recognizes selfless devotion, outstanding achievements in raising funds and awareness for
What better motivation to achieve a personal best than running alongside more than 1,200
St Jude families? This sets a new record for the marathon.
Phi Delta Chi professional pharmacy fraternity plans to raise an additional $1 million by 2029 on the heels of a $1 million pledge to
St. Jude two years ahead of schedule.
Art inspired by
St. Jude patient Bridget and brought to life as a sculpture by artist Tylur French makes a debut on Carnival’s newest ship, Carnival Celebration.
Social media takeovers, immersive experiences, pop-up store and livestreams connect donors to the lifesaving mission of
St. Jude on November 29.
St. Jude National Outreach Director Marlo Thomas will highlight patient stories and progress by
St. Jude in fighting childhood cancer and other life-threatening diseases.
Daniel J. Blair, PhD, wins award for early-career scientists working on breakthrough discoveries in health, medicine and science.
The list is based on papers ranked in the top 1% by citations— how often a research paper is referenced by other investigators in their work.
St. Jude is one of the first charities to top $15 million in donations from AmazonSmile shoppers.
Tickets for the 2023 Kansas City giveaway will support cutting-edge research and world class treatment by
Retailers will offer expanded in-store and online capabilities,
St. Jude will launch a virtual shop to support kids with cancer and other life-threatening diseases.
During Childhood Cancer Awareness Month, more than 61,000 people at 75 in-person events across the U.S. stepped up to help end childhood cancer by participating.
Representatives from the radio, television and digital media industries, as well as celebrities, influencers, executives and corporate partners attended the seminar.
St. Jude scientists studied the role of RNA splicing defects in Alzheimer’s disease, revealing degeneration and toxicity caused by neuron hyperexcitability.
The Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute and
St. Jude announced the largest academic collaboration of its kind.
Cellular response to low oxygen also increases fetal hemoglobin expression in adults, which could lead to novel treatments for some genetic anemias.
Dave Lew, Albert Crews and Jennifer Hart have also been named to key leadership roles to support fundraising and awareness for
Alabama singer Randy Owen presented McCreery with the award at Country Cares, an annual gathering of music artists and professionals who support
Cell biologist Chi-Lun Chang, PhD, was awarded a 5-year $2.7 million grant to “push the boundaries of biomedical science.”
An astronaut, a doctor and a non-profit executive are honored for outstanding achievements in advancing the lifesaving mission of
St. Jude patient fathers will join more than 2,000 registered athletes from 16 countries and 47 U.S. states in West Tennessee for the second year of this event.
St. Jude Children’s Research Hospital reveal that childhood cancer survivors with disadvantaged socio-demographic factors are over 7 times more likely to experience severe symptom burdens.
St. Jude scientists identified the mechanism by which Williams-Beuren Syndrome enhances the ability to discriminate between sounds as interneuron hyperexcitability in the auditory cortex.
A tool created by
St. Jude scientists may increase the safety of gene and cell therapy by finding safe places to add genes to human DNA.
St. Jude scientists found that group 3 and 4 medulloblastoma arise from the rhombic lip, knowledge that may help improve research models and therapeutic development.
St. Jude Comprehensive Cancer Center award extends its current $35 million, five-year Cancer Center Support Grant (CCSG) for an additional two years.
St. Jude department recognized for the first time with 2022 Environmental Services Department of the Year Award.
St. Jude will be hosting 75 in-person
St. Jude Walk/Run events across U.S. this year on Saturday, September 24.
This September, the Relay FM podcast network is rallying listeners and fans in an 8-hour live podcastathon to support
St. Jude scientists have completed the largest study of families affected by Hodgkin lymphoma and identified novel variants linked to cancer predisposition.
Celebrities, supporters to celebrate #30DaysForSt.Jude, #ShowYourGold on social media, communities prepare for national
St. Jude Walk/Run, retail customers to round up donations.
The Gaines family will help support Childhood Cancer Awareness Month,
Thanks and Giving holiday campaign and shares the
St. Jude mission year around.
St. Jude Children’s Research Hospital discovered how some cancer cells survive treatment and cause cancer to recur, along with a potential way to stop the process.
St. Jude scientists sequenced the most childhood cancer samples from a single cancer type ever in a landmark study.
St. Jude Global and partners help Ukrainian children with cancer and blood disorders continue treatment, creating a model for responses to other crises.
St. Jude scientists created an LCK targeted PROTAC able to kill T-cell acute lymphoblastic leukemia cells.
Morikawa’s generosity provided an opportunity for
St. Jude kids to learn from one of the best in the sport before his appearance at the 2022 FedEx
St. Jude Championship.
St. Jude scientists developed a simple method to select for more effective cancer-destroying CAR T cells to treat T-ALL.
New this year, volunteers can fundraise to support the largest single-day fundraising event for
St. Jude and one of the biggest events in Memphis — Dec. 1-3, 2022.
This annual concert tees off week-long events for FedEx
St. Jude Championship of golf.
Cheers rose up from the
St. Jude Children’s Research Hospital campus as hundreds of runners hit the pavement for the 41st annual Memphis to Peoria Run.
This highly anticipated PGA TOUR stop in Memphis benefits
St. Jude Children’s Research Hospital.
St. Jude scientists have created a proof-of-principle approach to improve engager T-cell therapy for difficult-to-treat acute myeloid leukemia.
The Good Manufacturing Practices (GMP) facility produces highly specialized biopharmaceuticals and other biological products for the hospital’s clinics.
ALSAC joined the National Bar Association during its 97th annual convention in Memphis on July 24 to celebrate diversity, equity, inclusion and belonging.
St. Jude scientists created a way to identify childhood cancer patients at diagnosis who are at the highest risk for developing severe obesity as adults.
The crew of the Polaris Dawn mission, which will push the boundaries of human space travel, took time out of training yesterday to make their first official visit to
First-year college student and cancer survivor Cross developed a love for golf during his treatment at
Honorees come from multiple walks of life and represent groups and individuals both new and established in their wonderful commitment to
St. Jude found an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion which revealed a promising treatment approach in the lab.
Six-year plan will now commit $12.9 billion to support 2,300 jobs, among other priorities.
St. Jude High School and College Research Immersion Program introduces science to a diverse group of students
The annual celebration included a panel on women in leadership, breakout sessions and tours of
St. Jude scientists have shown how the presence or absence of primary cilia contribute to specific types of the most common malignant childhood brain tumor.
Two plaques honoring Dr. Jackson were unveiled at
St. Jude as supporters and family members attended a June 23 event.
St. Jude scientists developed a method that could improve CAR T-cell therapies by identifying the early cells that become effective at killing cancer.
Tosh is the first
St. Jude patient to reach this milestone and was recognized at institution’s 60th anniversary celebration
New collaboration with multiple organizations is part of national effort to provide equity in STEM education.
St. Jude immunologists identified proteins that help decide T cell fate and used the finding to improve CAR-T cell therapy in a solid tumor model.
Nonprofits are featured for the first time in a survey of most trusted brands.
Tournament officials recently announced a charitable impact figure of over $8.6 million was generated for the hospital from the 2021 event.
St. Jude Children’s Research Hospital recognized among hospitals delivering exceptionally high-quality care
St. Jude scientists identified a genetic difference in childhood cancer survivors treated with chemotherapy that predisposes them to heart problems as adults.
St. Jude scientists are studying how the temperature at which protein structures are captured can create "artifacts," – errors that cause misleading results.
Runners, supporters and volunteer fundraisers will sprint toward a fundraising goal of $14 million to benefit
St. Jude kids during this fitness event on Saturday, December 3.
Learn best practices and hear insights from
St. Jude oncologists, psychologists and scientists at the annual gathering of clinical oncology experts.
Feld Entertainment surprised
St. Jude patient Calvin by unveiling his artwork on a truck named Emoji Strong during its Monster Jam World Finals® in Orlando, Florida.
St. Jude scientists uncovered how one type of T cell creates two genetically identical, but functionally different, daughter cells.
This the first time researchers have identified the mechanism for closed-state inactivation. These approaches could be applied to other ion channels.
St. Jude scientists identified ZBP1 as a key contributor to the inflammatory cell death that drives morbidity and mortality in COVID-19 patients.
Hundreds of influencers, business leaders, entrepreneurs and supporters of
St. Jude convened in a virtual gathering on Thursday, May 5, for the annual
St. Jude Mom Boss Summit.
St. Jude scientists will discuss research on cellular therapies for pediatric cancer and more at the annual meeting.
Big data can cause big problems in rare disease genetics research. Scientists at
St. Jude created a systematic solution to find the inherited genes contributing to rare disease.
St. Jude demonstrate the role of chromatin regulation in cancer’s resistance to EZH2 inhibitors and offer a way to make treatment more effective.
In its 18th year, Emmy-nominated NFL Network host Rich Eisen kicked off his annual event at the Rose Bowl, in Pasadena, California.
RMS is the most common soft tissue sarcoma in children. When it recurs after therapy, the survival rate is only 30%.
St. Jude scientists and their Columbia University collaborators reveal how GPCR signaling is regulated with implications for drug development.
St. Jude scientists have found the first known example of a promoter ‘donation’ event from a retrotransposon causing a highly malignant childhood brain cancer.